kidney transplant renal transplant organ transplant kidney patient endstage kidney disease esrd kidney transplant typically classified deceaseddonor formerly known cadaveric livingdonor transplantation depending source donor organ livingdonor kidney transplants characterized genetically related livingrelated nonrelated livingunrelated transplants depending whether biological relationship exists donor recipient receiving kidney transplant person esrd must undergo thorough medical evaluation make sure healthy enough undergo transplant surgery deemed good candidate placed waiting list receive kidney deceased placed waiting list receive new kidney quickly may wait many years united states average waiting time three five transplant surgery new kidney usually placed lower abdomen belly persons two native kidneys usually taken unless medical reason people esrd receive kidney transplant generally live longer people esrd dialysis may better quality however kidney transplant recipients must remain immunosuppressants medications suppress immune system long new kidney working prevent body rejecting longterm immunosuppression puts higher risk infections kidney transplant rejection classified cellular rejection antibodymediated rejection antibodymediated rejection classified hyperacute acute chronic depending long transplant occurs rejection suspected kidney biopsy important regularly monitor new kidneys function measuring serum creatinine labs done least every three estimated kidney transplants performed worldwide came living first successful kidney transplant performed team including joseph murray recipient surgeon hartwell harrison surgeon donor murray awarded nobel prize physiology medicine one earliest mentions possibility kidney transplant american medical researcher simon flexner declared reading paper tendencies pathology university chicago would possible thenfuture diseased human organs substitution healthy ones surgery including arteries stomach kidneys surgeon yuriy vorony kherson ukraine attempted first human kidney transplant using kidney removed six hours earlier deceased donor reimplanted thigh measured kidney function using connection kidney skin first patient died two days later graft incompatible recipients blood group june successful transplant performed ruth tucker woman polycystic kidney disease dr richard little company mary hospital evergreen park illinois although donated kidney rejected ten months later immunosuppressive therapy available development effective antirejection drugs years intervening time gave tuckers remaining kidney time recover lived another five kidney transplant living patients undertaken necker hospital paris jean hamburger although kidney failed three first truly successful transplant kind occurred boston boston transplantation performed december brigham hospital performed joseph murray j hartwell harrison john p merrill others procedure done identical twins ronald richard herrick reduced problems immune reaction later work murray received nobel prize medicine recipient richard herrick died eight years transplantation due complications donor kidney unrelated charles rob william james jim dempster st marys hammersmith london carried first deceased donor transplant united kingdom unsuccessfulcitation needed july fred peter raper leeds performed first successful months deceased donor transplant uk year later first successful living kidney transplant uk occurred michael woodruff performed one identical twins november sultan qaboos university hospital oman performed successfully worlds youngest cadaveric kidney transplant work took place newborn weeks recipient survived years thanks couple organs transplanted routine use medication prevent treat acute rejection introduced deceased donor transplantation performed kidney easiest organ transplant tissue typing simple organ relatively easy remove implant live donors could used without difficulty event failure kidney dialysis available explained thomas starzls memoir factors explain starzls team others began kidney transplantation first type solid organ tramsplantation translate clinical practice attempting move liver transplantation heart transplantation types major barrier organ transplantation genetically nonidentical patients lay recipients immune system would treat transplanted kidney nonself immediately chronically reject thus medication suppress immune system essential however suppressing individuals immune system places individual greater risk infection cancer particularly skin cancer lymphoma addition side effects medications basis immunosuppressive regimens prednisolone corticosteroid prednisolone suppresses immune system longterm use high doses causes multitude side effects including glucose intolerance diabetes weight gain osteoporosis muscle weakness hypercholesterolemia cataract formation prednisolone alone usually inadequate prevent rejection transplanted kidney thus nonsteroid immunosuppressive agents needed also allow lower doses prednisolone include azathioprine mycophenolate ciclosporin tacrolimus indication kidney transplantation endstage renal disease esrd regardless primary cause defined glomerular filtration rate common diseases leading esrd include renovascular disease infection diabetes mellitus autoimmune conditions chronic glomerulonephritis lupus genetic causes include polycystic kidney disease number inborn errors metabolism commonest cause idiopathic ie unknown diabetes common known cause kidney transplantation accounting approximately united states majority renal transplant recipients dialysis peritoneal dialysis hemodialysis time transplantation however individuals chronic kidney disease living donor available may undergo preemptive transplantation dialysis needed patient put waiting list deceased donor transplant early enough may also occur predialysis potential kidney donors kidney recipients carefully screened assure positive outcomes contraindications receive kidney transplant include cardiac pulmonary insufficiency well hepatic disease cancers concurrent tobacco use morbid obesity also among indicators putting patient higher risk surgical complications kidney transplant requirements vary program program country country many programs place limits age eg person must certain age enter waiting list require one must good health aside kidney disease significant cardiovascular disease incurable terminal infectious diseases cancer often transplant exclusion criteria addition candidates typically screened determine compliant medications essential survival transplant people mental illness andor significant ongoing substance abuse issues may excluded hiv one point considered complete contraindication transplantation fear immunosuppressing someone depleted immune system would result progression disease however research seem suggest immunosuppressive drugs antiretrovirals may work synergistically help hiv viral cell counts prevent active rejection candidates significant elective surgery potential kidney donors carefully screened assure good long term outcomes screening includes medical psychosocial components sometimes donors successfully screened months process take longer especially test results indicate additional tests required total approval time six months identified important goal transplant centers avoid missed opportunities kidney transplant example intended recipient becomes ill transplant donor psychosocial screening attempts determine presence psychosocial problems might complicate donation lack social support aid post operative recovery coercion family members lack understanding medical risksguidance development programspecific living kidney donor medical evaluation protocols optn medical screening assesses general health surgical risk donor including conditions might indicate complications living single kidney also assesses whether donor diseases might transmitted recipient usually immunosuppressed assesses anatomy donors kidneys including differences size issues might complicate surgery determines immunological compatibility donor recipient specific rules vary transplant center key exclusion criteria often include since medication prevent rejection effective donors need similar recipients donated kidneys come deceased donors however utilisation living donors united states rise donated kidneys living varies country example kidneys transplanted spain came living spain citizens potential organ donors case death unless explicitly opt approximately one three donations us uk israel live potential donors carefully evaluated medical psychological grounds ensures donor fit surgery disease brings undue risk likelihood poor outcome either donor recipient psychological assessment ensure donor gives informed consent coerced countries paying organs illegal authorities may also seek ensure donation resulted financial transaction relationship donor recipient evolved years first successful living donor transplants identical twins live donors genetically related recipient however donor pool expanded emotionally related individuals spouses friends elasticity donor relationship stretched include acquaintances even strangers altruistic donors us transplant recipient chris strouth received kidney donor connected twitter believed first transplant arranged entirely social exchanges chains novel approach expand living donor pool february novel approach expand living donor pool resulted largest chain world involving participants organized national kidney record largest chain broken swap involving acceptance altruistic donors enabled chains transplants form kidney chains initiated altruistic donor donates kidney patient willing incompatible donor incompatible donor pays forward passes generosity another recipient also willing incompatible donor michael rees university toledo developed concept openended variation concept developed johns hopkins july altruistic donor kidney shipped via commercial airline cornell ucla thus triggering chain shipment living donor kidneys computermatching software algorithms cooperation transplant centers enabled longelaborate chains fda approved cedarssinai high dose ivig therapy reduces need living donor blood type abo compatible even tissue therapy reduced incidence recipients immune system rejecting donated kidney highly sensitized carefully screened kidney donors survival risk endstage renal disease appear similar general however recent studies suggest lifelong risk chronic kidney disease severalfold higher kidney donors although absolute risk still article new england journal medicine suggests persons one kidney including donated kidney transplantation avoid high protein diet limit protein intake less one gram per kilogram body weight per day order reduce longterm risk chronic kidney women donated kidney higher risk gestational hypertension preeclampsia matched nondonors similar indicators baseline traditionally donor procedure single incision inches cm live donation increasingly performed laparoscopic surgery reduces pain accelerates recovery donor operative time complications decreased significantly surgeon performed cases live donor kidney grafts higher longterm success rates deceased since increase use laparoscopic surgery number live donors increased advance leads decrease pain scarring swifter recovery potential boost donor numbers january first allrobotic kidney transplant performed saint barnabas medical center located livingston new jersey twoinch incision following six months team performed eight roboticassisted johns hopkins medical center healthy kidney removed donors vagina vaginal donations promise speed recovery reduce first donor chosen previously extraction performed using natural orifice transluminal endoscopic surgery endoscope inserted orifice internal incision external scar recent advance single port laparoscopy requiring one entry point navel another advance potential frequent use developing world people sell organs illegally people often grave exploited salespersons people travel make use kidneys often known transplant tourists practice opposed variety human rights groups including organs watch group established medical anthropologists instrumental exposing illegal international organ selling rings patients may increased complications owing poor infection control lower medical surgical standards one surgeon said organ trade could legalised uk prevent tourism seen national kidney research fund answer deficit illegal black market donors may get sufficient afteroperation price kidney may middlemen take money operation dangerous donor receiver buyer often gets hepatitis legal markets iran price kidney article gary becker julio elias introducing incentives market live cadaveric organ said free market could help solve problem scarcity organ transplants economic modeling able estimate price tag human kidneys human livers jason brennan peter jaworski georgetown university also argued moral objections market organs inherent market rather activity monetary compensation organ donors form reimbursement outofpocket expenses legalised including united united deceased donors divided two groups although braindead heart beating donors considered medically legally dead donors heart continues pump maintain circulation makes possible surgeons start operating organs still perfused supplied blood operation aorta cannulated donors blood replaced icecold storage solution uw viaspan htk perfadex depending organs transplanted one solution may used simultaneously due temperature solution since large amounts cold naclsolution poured organs rapid cooling heart stop pumping donation cardiac death donors patients meet braindead criteria due unlikely chance recovery elected via living family support withdrawn procedure treatment discontinued mechanical ventilation shut time death pronounced patient rushed operating room organs recovered storage solution flushed organs since blood longer circulated coagulation must prevented large amounts anticoagulation agents heparin several ethical procedural guidelines must followed importantly organ recovery team participate patients care manner death declared many governments passed laws whereby default optin system order increase number donors since december human transplantation wales act passed welsh government enabled optout organ donation register first country uk legislation deemed consent whereby citizens considered objection becoming donor unless opted approval epclusa number donors increased medication allows curing hepatitis c positive individuals increased pool available university alabama birmingham announced first peerreviewed research outlining successful transplant genetically modified clinicalgrade pig kidneys braindead human individual replacing recipients native kidneys study published american journal transplantation researchers tested first human preclinical model transplanting genetically modified pig kidneys humans recipient study native kidneys removed received two genetically modified pig kidneys place organs came genetically modified pig pathogenfree general donor recipient abo blood group crossmatch human leukocyte antigen hla compatible potential living donor incompatible recipient donor could exchanged compatible kidney kidney exchange also known kidney paired donation chains recently gained popularitycitation needed effort reduce risk rejection incompatible transplantation aboincompatible desensitization protocols utilizing intravenous immunoglobulin ivig developed aim reduce abo hla antibodies recipient may donor fda approved cedarssinai high dose ivig therapy reduces need living donor blood type abo compatible even tissue therapy reduced incidence recipients immune system rejecting donated kidney highly sensitized experimental protocols developed aboincompatible transplants using increased immunosuppression plasmapheresis techniques improved important study longterm outcomes japan number programs around world routinely performing aboincompatible level sensitization donor hla antigens determined performing panel reactive antibody test potential recipient united states deceased donor kidney transplants hla mismatch however hla matching relatively minor predictor transplant outcomes fact living nonrelated donors almost common living geneticallyrelated donorscitation needed cases barely functioning existing kidneys removed removal shown increase rates surgical morbidity therefore kidney usually placed location different original kidney often iliac fossa often necessary use different blood supply donor ureter anastomosed recipient bladder cases ureteral stent placed time anastomosis assumption allows better drainage healing however using modified lichgregoir technique gaetano ciancio developed technique longer requires ureteral stenting avoiding many stent related disagreement surgical textbooks regarding side recipients pelvis use receiving transplant campbells urology recommends placing donor kidney recipients contralateral side ie left sided kidney would transplanted recipients right side ensure renal pelvis ureter anterior event future surgeries required instance doubt whether enough space recipients pelvis donors kidney textbook recommends using right side right side wider choice arteries veins reconstruction glens urological surgery recommends putting kidney contralateral side circumstances reason explicitly put forth however one assume rationale similar campbell ie ensure renal pelvis ureter anterior event future surgical correction becomes necessary smiths urology states either side recipients pelvis acceptable however right vessels horizontal respect therefore easier use anastomoses unclear meant words horizontal occasionally kidney transplanted together pancreas university minnesota surgeons richard lillehei william kelly perform first successful simultaneous pancreaskidney transplant world done patients diabetes mellitus type diabetes due destruction beta cells pancreas diabetes caused kidney failure diabetic nephropathy almost always deceased donor transplant living donor partial pancreas transplants done individuals diabetes kidney failure advantages earlier transplant living donor available far superior risks continued dialysis combined kidney pancreas available deceased donorcitation needed patient either receive living kidney followed donor pancreas later date pak pancreasafterkidney combined kidneypancreas donor skp simultaneous kidneypancreas transplanting islet cells pancreas still experimental stage shows promise involves taking deceased donor pancreas breaking extracting islet cells make insulin cells injected catheter recipient generally lodge liver recipient still needs take immunosuppressants avoid rejection surgery required people need two three injections many completely insulinfree transplant surgery takes three donor kidney placed lower abdomen blood vessels connected arteries veins recipients body complete blood allowed flow kidney final step connecting ureter donor kidney bladder cases kidney soon start producing urine depending quality new kidney usually begins functioning immediately living donor kidneys normally require days reach normal functioning levels cadaveric donations stretch interval days hospital stay typically days complications arise additional medications diuretics may administered help kidney produce urine immunosuppressant drugs used suppress immune system rejecting donor kidney medicines must taken rest recipients life common medication regimen today mixture tacrolimus mycophenolate prednisolone recipients may instead take ciclosporin sirolimus azathioprine risk early rejection transplanted kidney increased corticosteroids avoided withdrawn ciclosporin considered breakthrough immunosuppressive first discovered ironically causes nephrotoxicity result iatrogenic damage newly transplanted kidney tacrolimus similar drug also causes nephrotoxicity blood levels must monitored closely recipient seems declining kidney function proteinuria kidney transplant biopsy may necessary determine whether due rejection ciclosporin tacrolimus intoxication post operatively kidneys periodically assessed ultrasound assess imaging physiologic changes accompany transplant rejection imaging also allows evaluation supportive structures anastomosed transplant artery vein ureter ensure stable appearance major sonographic scale quantitative ultrasound assessment multipoint assessment resistive index ri beginning main renal artery vein ending arcuate vessels calculated follows normal value upper limits posttransplantation radioisotope renography used diagnosis vascular urological also early posttransplantation renography used assessment delayed graft kidney transplant recipients discouraged consuming grapefruit pomegranate green tea products food products known interact transplant medications specifically tacrolimus cyclosporin sirolimus blood levels drugs may increased potentially leading problems transplant may include alloimmune injury recurrent glomerulonephritis major causes transplant failure within year posttransplant majority transplant losses due technical issues transplant vascular complications losses acute rejection glomerulonephritis less common causes later causes transplant failure year greater transplantation include chronic rejection losses glomerulonephritis infections due immunosuppressant drugs used people kidney transplants commonly occur mucocutaneous areas urinary tract respiratory tract common infective agents bacterial viral fungal protozoan viral illnesses common agents human cytomegalovirus herpes simplex herpes zoster cytomegalovirus cmv common opportunistic infection may occur kidney solid organ transplants risk factor graft failure acute bk virus increasingly recognised transplant risk factor may lead kidney disease transplant failure infection cause death one third people renal transplants pneumonias account patient deaths delayed graft function defined need hemodialysis within week kidney transplant result excessive perfusion related injury delayed graft function occurs approximately recipients kidneys deceased delayed graft function leads graft fibrosis inflammation risk factor graft failure hypothermic pulsatile machine perfusion using machine perfuse donor kidneys ex vivo cold solution rather static cold storage associated lower incidence delayed graft deceased donor kidneys higher kidney donor profile index kdpi scores score used determine suitability donor kidneys based factors age donor cause death kidney function time death history diabetes hypertension etcwith higher scores indicating lower suitability associated increased risk delayed graft acute rejection another possible complication kidney transplantation graded according banff classification incorporates various serologic molecular histologic markers determine severity rejection acute rejection classified tcell mediated antibody mediated mixed rejection common causes acute rejection include inadequate immunosuppression treatment noncompliance immunosuppressive clinical acute rejection seen approximately kidney transplants within first year transplantation presents kidney rejection associated kidney subclinical rejection seen approximately kidney transplants within first year transplantation presents rejection incidentally seen biopsy normal kidney acute rejection onset months later transplantation associated worse acute rejection onset less year transplantation usually cell mediated whereas onset greater year transplantation associated mixed cell antibody mediated mortality rate due kidney transplant recipients significantly higher general thought due immunosuppression status medical comorbidities transplant vaccination booster doses recommended kidney transplant postoperative bleeding following kidney transplant seen postoperative bleeding following kidney transplant seen postoperative bleeding following kidney transplant seen postoperative bleeding following kidney transplant seen kidney transplantation lifeextending typical patient live years longer kidney transplant kept increase longevity greater younger patients even recipients oldest group data gain average four years life graft patient survival transplantation also improved time year graft survival rates deceased donor transplants increasing year patient survival rate increasing survival benefit among recipients kidney transplant living dead recipients compared long term dialysis without kidney transplant including comorbidities type diabetes advanced age obesity hla people generally energy lessrestricted diet fewer complications kidney transplant stay conventional dialysiscitation needed studies seem suggest longer patient dialysis transplant less time kidney last clear occurs underscores need rapid referral transplant program ideally kidney transplant preemptive ie take place patient begins dialysis reason kidneys fail time transplantation elucidated recent years apart recurrence original kidney disease rejection mainly antibodymediated rejection progressive scarring multifactorial also play decisive avoiding rejection strict medication adherence utmost importance avoid failure kidney transplantcitation needed least four professional athletes made comeback sport receiving transplant new zealand rugby union player jonah lomu germancroatian soccer player ivan klasnić nba basketballers sean elliott alonzo mourningcitation needed live kidney donors prognostic studies potentially confounded selection bias wherein kidney donors selected among people healthier general population matching corresponding healthy control group appears difference overall longterm mortality rates among kidney march addition nationality transplantation rates differ based race sex income study done patients beginning longterm dialysis showed sociodemographic barriers renal transplantation relevant even patients transplant example different sociodemographic groups express different interest complete pretransplant workup different rates previous efforts create fair transplantation policies focused patients currently transplantation waiting list transplant recipients must take immunosuppressive antirejection drugs long transplanted kidney functions routine immunosuppressives tacrolimus prograf mycophenolate cellcept prednisolone drugs cost per month united states congress passed law restricts medicare paying three years drugs unless patient otherwise medicareeligible transplant programs may transplant patient unless patient reasonable plan pay medication medicare coverage expires however patients almost never turned financial reasons alone half endstage renal disease patients medicare coverage provision repealed december repeal come effect january people medicare applied medicare time procedure lifetime coverage posttransplant united network organ sharing oversees organ transplants united states allows transplant candidates register two transplant centers practice known multiple practice shown effective mitigating dramatic geographic disparity waiting time organ particularly patients residing highdemand regions practice multiplelisting also endorsed medical see also categorykidney transplant recipients list organ transplant donors recipients httpsenwikipediaorgwikikidneytransplantation